Literature DB >> 15561926

Liver X receptor activation stimulates insulin secretion via modulation of glucose and lipid metabolism in pancreatic beta-cells.

Alexander M Efanov1, Sabine Sewing, Krister Bokvist, Jesper Gromada.   

Abstract

Liver X receptors (LXRs) alpha and beta, transcription factors of a nuclear hormone receptor family, are expressed in pancreatic islets as well as glucagon-secreting and insulin-secreting cell lines. Culture of pancreatic islets or insulin-secreting MIN6 cells with a LXR specific agonist T0901317 caused an increase in glucose-dependent insulin secretion and islet insulin content. The stimulatory effect of T0901317 on insulin secretion was observed only after >72 h of islet culture with the compound. In MIN6 cells, T0901317 increased protein expression of lipogenic enzymes, fatty acid synthase, and acetyl-CoA carboxylase. LXR activation also produced an increase in glucokinase protein and pyruvate carboxylase (PC) activity levels. The PC inhibitor phenylacetic acid abolished the increase in insulin secretion in cells treated with T0901317. The results suggest that LXRs can control insulin secretion and biosynthesis via regulation of glucose and lipid metabolism in pancreatic beta-cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15561926     DOI: 10.2337/diabetes.53.suppl_3.s75

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  50 in total

1.  Genetic variation within the NR1H2 gene encoding liver X receptor β associates with insulin secretion in subjects at increased risk for type 2 diabetes.

Authors:  Caroline Ketterer; Karsten Müssig; Fausto Machicao; Norbert Stefan; Andreas Fritsche; Hans-Ulrich Häring; Harald Staiger
Journal:  J Mol Med (Berl)       Date:  2010-11-02       Impact factor: 4.599

Review 2.  Leucine metabolism in regulation of insulin secretion from pancreatic beta cells.

Authors:  Jichun Yang; Yujing Chi; Brant R Burkhardt; Youfei Guan; Bryan A Wolf
Journal:  Nutr Rev       Date:  2010-05       Impact factor: 7.110

3.  Quantitative proteomic profiling reveals hepatic lipogenesis and liver X receptor activation in the PANDER transgenic model.

Authors:  Mark G Athanason; Whitney A Ratliff; Dale Chaput; Catherine B MarElia; Melanie N Kuehl; Stanley M Stevens; Brant R Burkhardt
Journal:  Mol Cell Endocrinol       Date:  2016-07-07       Impact factor: 4.102

4.  Liver X receptor regulates hepatic nuclear O-GlcNAc signaling and carbohydrate responsive element-binding protein activity.

Authors:  Christian Bindesbøll; Qiong Fan; Rikke C Nørgaard; Laura MacPherson; Hai-Bin Ruan; Jing Wu; Thomas Å Pedersen; Knut R Steffensen; Xiaoyong Yang; Jason Matthews; Susanne Mandrup; Hilde I Nebb; Line M Grønning-Wang
Journal:  J Lipid Res       Date:  2015-02-27       Impact factor: 5.922

Review 5.  Liver X receptors as integrators of metabolic and inflammatory signaling.

Authors:  Noam Zelcer; Peter Tontonoz
Journal:  J Clin Invest       Date:  2006-03       Impact factor: 14.808

6.  The synthetic liver X receptor agonist GW3965 reduces tissue factor production and inflammatory responses in human islets in vitro.

Authors:  H Scholz; T Lund; M K Dahle; J L Collins; O Korsgren; J E Wang; A Foss
Journal:  Diabetologia       Date:  2009-05-05       Impact factor: 10.122

Review 7.  Liver X receptors as therapeutic targets in metabolism and atherosclerosis.

Authors:  Takashi Nomiyama; Dennis Bruemmer
Journal:  Curr Atheroscler Rep       Date:  2008-02       Impact factor: 5.113

8.  Liver X receptor agonists ameliorate TNFalpha-induced insulin resistance in murine brown adipocytes by downregulating protein tyrosine phosphatase-1B gene expression.

Authors:  S Fernández-Veledo; I Nieto-Vazquez; C M Rondinone; M Lorenzo
Journal:  Diabetologia       Date:  2006-10-27       Impact factor: 10.122

9.  Research resource: nuclear hormone receptor expression in the endocrine pancreas.

Authors:  Jen-Chieh Chuang; Ji-Young Cha; James C Garmey; Raghavendra G Mirmira; Joyce J Repa
Journal:  Mol Endocrinol       Date:  2008-07-31

10.  Chronic suppression of acetyl-CoA carboxylase 1 in beta-cells impairs insulin secretion via inhibition of glucose rather than lipid metabolism.

Authors:  Sarah M Ronnebaum; Jamie W Joseph; Olga Ilkayeva; Shawn C Burgess; Danhong Lu; Thomas C Becker; A Dean Sherry; Christopher B Newgard
Journal:  J Biol Chem       Date:  2008-04-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.